Aberrant expression and potency as a cancer immunotherapy target of alpha-methylacyl-coenzyme A racemase in prostate cancer.

Source:http://linkedlifedata.com/resource/pubmed/id/20003233

Download in:

View as

General Info

PMID
20003233